These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12685116)
1. [Telithromycin: a new therapeutic option for community-acquired respiratory infection]. Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116 [No Abstract] [Full Text] [Related]
2. Clinical management of respiratory tract infections in the community: experience with telithromycin. Quintiliani R Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852 [TBL] [Abstract][Full Text] [Related]
3. The ketolides: a critical review. Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046 [TBL] [Abstract][Full Text] [Related]
4. A pooled analysis of telithromycin in the treatment of community-acquired respiratory tract infections in adults. Carbon C Infection; 2003 Oct; 31(5):308-17. PubMed ID: 14556055 [TBL] [Abstract][Full Text] [Related]
5. Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. Fogarty CM; Kohno S; Buchanan P; Aubier M; Baz M J Antimicrob Chemother; 2003 Apr; 51(4):947-55. PubMed ID: 12654763 [TBL] [Abstract][Full Text] [Related]
6. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting. Clark JP; Langston E Mayo Clin Proc; 2003 Sep; 78(9):1113-24. PubMed ID: 12962166 [TBL] [Abstract][Full Text] [Related]
8. Telithromycin (Ketek) for respiratory infections. Med Lett Drugs Ther; 2004 Aug; 46(1189):66-8. PubMed ID: 15314586 [No Abstract] [Full Text] [Related]
9. Telithromycin: the first ketolide antibacterial for the treatment of community-acquired respiratory tract infections. Lorenz J Int J Clin Pract; 2003; 57(6):519-29. PubMed ID: 12918892 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of ketolides in the treatment of respiratory tract infections. Reinert RR J Antimicrob Chemother; 2004 Jun; 53(6):918-27. PubMed ID: 15117934 [TBL] [Abstract][Full Text] [Related]
11. [Telithromycin, a once-a-day ketolide in the treatment of community acquired pneumonia]. Carbon C Presse Med; 2000 Dec; 29(37):2042-3. PubMed ID: 11155730 [TBL] [Abstract][Full Text] [Related]
14. Telithromycin. Aventis Pharma. Johnson AP Curr Opin Investig Drugs; 2001 Dec; 2(12):1691-701. PubMed ID: 11892930 [TBL] [Abstract][Full Text] [Related]
15. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections? Carter PL Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591 [TBL] [Abstract][Full Text] [Related]
16. [Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections]. Casellas JM; Visser M; Mac Dougall N; Coco B; Tomé G; Gliosca L; Rev Esp Quimioter; 2001 Sep; 14(3):269-74. PubMed ID: 11753448 [TBL] [Abstract][Full Text] [Related]
17. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. Felmingham D J Infect; 2002 Feb; 44 Suppl A():3-10. PubMed ID: 12150493 [TBL] [Abstract][Full Text] [Related]
18. Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review. Fogarty CM; Buchanan P; Aubier M; Baz M; van Rensburg D; Rangaraju M; Nusrat R Int J Infect Dis; 2006 Mar; 10(2):136-47. PubMed ID: 16183318 [TBL] [Abstract][Full Text] [Related]
19. Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials. Li XM; Wang FC; Yang F; Jin YH Chin Med J (Engl); 2013; 126(11):2179-85. PubMed ID: 23769580 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of new antibacterial therapies in at-risk populations. Lorenz J J Infect; 2002 Feb; 44 Suppl A():25-30. PubMed ID: 12150492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]